Bipolar II disorder : modelling, measuring and managing [E-book]

Contributor(s):

Parker, Gordon [editor]

Publication details: Cambridge : Cambridge University Press, 2019Edition: 3rd edDescription: xiii, 307pISBN:

9781108355902

Subject(s):

NLM classification:

WM 207.

Online resources:

Summary: The lifetime risk of developing bipolar II disorder is 5-7%, yet the condition is often poorly detected. Mood elevation states are less extreme than in bipolar I disorder although the depressive episodes are usually severe. When correctly treated, the outcome is positive, but bipolar II is often poorly managed, resulting in a high suicide rate. This is the only academic and clinical management review focused entirely on bipolar II, scrutinizing history, epidemiology, burden and neurobiology and including an extensive clinical debate by international experts about effective management strategies. Now in its third edition, this book features new chapters on the limitations to clinical treatment trials and perinatal management nuances. In a completely new section, international experts offer their personal responses and distinctive wisdom to key management issues and allow the reader to observe a variety of opinions.

Holdings
Item type	Home library	Class number	Status
Electronic book	CEME Library (NELFT) On website	WM 207 (Browse shelf(Opens below))	Available
Electronic book	South London and Maudsley Trust Library On website	WM 207 (Browse shelf(Opens below))	Available
Electronic book	Thorpe Coombe Library On website	WM 207 (Browse shelf(Opens below))	Available

Previous edition: 2012.

The lifetime risk of developing bipolar II disorder is 5-7%, yet the condition is often poorly detected. Mood elevation states are less extreme than in bipolar I disorder although the depressive episodes are usually severe. When correctly treated, the outcome is positive, but bipolar II is often poorly managed, resulting in a high suicide rate. This is the only academic and clinical management review focused entirely on bipolar II, scrutinizing history, epidemiology, burden and neurobiology and including an extensive clinical debate by international experts about effective management strategies. Now in its third edition, this book features new chapters on the limitations to clinical treatment trials and perinatal management nuances. In a completely new section, international experts offer their personal responses and distinctive wisdom to key management issues and allow the reader to observe a variety of opinions.

There are no comments on this title.

to post a comment.